Primary glomerulonephritides
- PMID: 26921911
- DOI: 10.1016/S0140-6736(16)00272-5
Primary glomerulonephritides
Abstract
Most glomerulonephritides, even the more common types, are rare diseases. They are nevertheless important since they frequently affect young people, often cannot be cured, and can lead to chronic kidney disease, including end-stage renal failure, with associated morbidity and cost. For example, in young adults, IgA nephropathy is the most common cause of end-stage renal disease. In this Seminar, we summarise existing knowledge of clinical signs, pathogenesis, prognosis, and treatment of glomerulonephritides, with a particular focus on data published between 2008 and 2015, and the most common European glomerulonephritis types, namely IgA nephropathy, membranous glomerulonephritis, minimal change disease, focal segmental glomerulosclerosis, membranoproliferative glomerulonephritis, and the rare complement-associated glomerulonephritides such as dense deposit disease and C3 glomerulonephritis.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
[Glomerulonephritides].Internist (Berl). 2015 Nov;56(11):1277-85; quiz 1286-7. doi: 10.1007/s00108-015-3781-1. Internist (Berl). 2015. PMID: 26440274 Review. German.
-
[Primary and secondary glomerular diseases].Dtsch Med Wochenschr. 2011 Apr;136(14):703-5. doi: 10.1055/s-0031-1274568. Epub 2011 Mar 29. Dtsch Med Wochenschr. 2011. PMID: 21448831 Review. German. No abstract available.
-
Treatment of glomerulonephritis in the elderly.Semin Nephrol. 2000 May;20(3):256-64. Semin Nephrol. 2000. PMID: 10855935 Review.
-
Chronic glomerulonephritis in childhood. Membranoproliferative glomerulonephritis, Henoch-Schönlein purpura nephritis, and IgA nephropathy.Pediatr Clin North Am. 1995 Dec;42(6):1487-503. doi: 10.1016/s0031-3955(16)40095-7. Pediatr Clin North Am. 1995. PMID: 8614597 Review.
-
[Histological classification of chronic glomerular diseases].Rev Prat. 2003 Nov 30;53(18):2005-12. Rev Prat. 2003. PMID: 15008214 Review. French.
Cited by
-
Complement and Podocytopathies: Do We Have a New Biomarker?Kidney Int Rep. 2024 Jan 29;9(3):520-522. doi: 10.1016/j.ekir.2024.01.037. eCollection 2024 Mar. Kidney Int Rep. 2024. PMID: 38481505 Free PMC article. No abstract available.
-
The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies.Front Nephrol. 2024 Feb 1;3:1346769. doi: 10.3389/fneph.2023.1346769. eCollection 2023. Front Nephrol. 2024. PMID: 38362118 Free PMC article. Review.
-
Defining the threshold: triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio's non-linear impact on tubular atrophy in primary membranous nephropathy.Front Endocrinol (Lausanne). 2024 Jan 24;15:1322646. doi: 10.3389/fendo.2024.1322646. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38327562 Free PMC article.
-
Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectives.J Nanobiotechnology. 2024 Jan 3;22(1):9. doi: 10.1186/s12951-023-02257-8. J Nanobiotechnology. 2024. PMID: 38169389 Free PMC article. Review.
-
Mucosal-associated invariant T cells contribute to suppression of inflammatory myeloid cells in immune-mediated kidney disease.Nat Commun. 2023 Nov 15;14(1):7372. doi: 10.1038/s41467-023-43269-0. Nat Commun. 2023. PMID: 37968302 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
